New SEC Form D filing
Enumera Molecular, Inc., 2026-07-31
A new SEC Form D private-offering notice from Ann Arbor, MI, a $17,375,672 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Life science company developing a low cost molecular counting platform for liquid biopsy and clinical genomic testing
Filed 2026-07-31Filed to raise $17,375,672First money in 2026-07-16Raised so far $12,325,344HQ (as filed) Ann Arbor, MISector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified enumeramolecular.com↗Named in the filing 4 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- iReprogram, Inc, 2026-08-13, $25M, Ann Arbor, MI
- Conexeu Sciences Inc., 2026-07-31, $63K, Reno, NV
- 2DALOOP, CORP., 2026-08-12, Sterling Heights, MI
- ORF Biologics, Inc., 2026-07-31, $2.5M, Tiffin, IA
- Mixel Studio, Inc., 2026-08-03, $750K, Ann Arbor, MI
- Ratio Therapeutics, Inc., 2026-07-31, $70M, Boston, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.